ERBB4 and carcinoma: In a study by our group comparing the expression and distribution of ErbB receptors between HNSCCs and adjacent normal mucosa, ErbB4 was overexpressed in ~26% of the investigated carcinomas and, in addition to cytoplasmic staining, a strong nuclear ErbB4 immunostaining was observed in ~18% of carcinomas (26).